FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program November 19, 2024 Issue Brief The Centers for Medicare & Medicaid Services (CMS) recently concluded the first round of negotiation for the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and CMS’s implementation of the program, with a focus on the details that apply for 2027, the second year that negotiated prices will be available under the program.
Men Who Report Not Seeing a Doctor in the Past 12 Months Due to Cost by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Men Who Report Having No Personal Doctor/Health Care Provider by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Average Number of Poor Mental Health Days Reported in the Last 30 Days Among All Men by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Women Who Report Fair or Poor Health Status by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Men Who Report Fair or Poor Health Status, by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Adults Who Report Fair or Poor Health Status by Race/Ethnicity November 19, 2024 State Indicator disparity, Disparities
Adults Who Report Participation in Any Physical Activity or Exercise by Race/Ethnicity November 19, 2024 State Indicator
